An elderly Native American woman has tested positive for TB. What is another name for this condition?

Choice A rationale

Barrier contraceptives are recommended for women taking HMG-CoA reductase inhibitors due to the potential teratogenic effects of these drugs. This precaution is crucial as these medications can cause fetal harm if used during pregnancy.

Choice B rationale

While ophthalmic examinations may be important for other medications, they are not a primary concern for HMG-CoA reductase inhibitors. These drugs mainly affect cholesterol synthesis and have less direct impact on vision.

Choice C rationale

Although a cholesterol-lowering diet is beneficial, it is not the primary teaching point when discussing HMG-CoA reductase inhibitors. The emphasis should be on medication adherence and managing potential adverse effects.

Choice D rationale

Reporting respiratory symptoms is important for many medications but is not the primary focus for HMG-CoA reductase inhibitors. The priority is to inform patients about the importance of contraception and potential side effects related to the medication.

Choice A rationale

Platelet count measures the number of platelets in the blood, which are essential for blood clotting. However, it is not specific to monitoring the anticoagulant effects of warfarin.

Choice B rationale

Activated thromboplastin time (APT) measures the intrinsic pathway of coagulation and is typically used to monitor heparin therapy, not warfarin.

Choice C rationale

Red blood count (RBC) measures the number of red blood cells in the blood, which can indicate anemia but is unrelated to the anticoagulant effects of warfarin.

Choice D rationale

Prothrombin time (PT) and international normalized ratio (INR) are specific tests used to monitor the anticoagulant effects of warfarin. PT measures the time it takes for blood to clot, and INR standardizes this measurement to ensure consistency across different laboratories.